- Home
- ALLR vs SSY Comparison
ALLR vs SSY Comparison
Compare ALLR & SSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLR
- SSY
- Stock Information
- Founded
- ALLR 2004
- SSY 1959
- Country
- ALLR United States
- SSY United States
- Employees
- ALLR N/A
- SSY N/A
- Industry
- ALLR Biotechnology: Pharmaceutical Preparations
- SSY Hospital/Nursing Management
- Sector
- ALLR Health Care
- SSY Health Care
- Exchange
- ALLR Nasdaq
- SSY Nasdaq
- Market Cap
- ALLR 4.5M
- SSY 5.3M
- IPO Year
- ALLR N/A
- SSY N/A
- Fundamental
- Price
- ALLR $1.05
- SSY $0.77
- Analyst Decision
- ALLR
- SSY
- Analyst Count
- ALLR 0
- SSY 0
- Target Price
- ALLR N/A
- SSY N/A
- AVG Volume (30 Days)
- ALLR 218.5K
- SSY 17.6K
- Earning Date
- ALLR 11-14-2024
- SSY 02-11-2025
- Dividend Yield
- ALLR N/A
- SSY N/A
- EPS Growth
- ALLR N/A
- SSY N/A
- EPS
- ALLR N/A
- SSY N/A
- Revenue
- ALLR N/A
- SSY $31,808,000.00
- Revenue This Year
- ALLR N/A
- SSY N/A
- Revenue Next Year
- ALLR N/A
- SSY N/A
- P/E Ratio
- ALLR N/A
- SSY N/A
- Revenue Growth
- ALLR N/A
- SSY N/A
- 52 Week Low
- ALLR $0.90
- SSY $0.53
- 52 Week High
- ALLR $378.00
- SSY $0.98
- Technical
- Relative Strength Index (RSI)
- ALLR 39.84
- SSY 47.08
- Support Level
- ALLR $0.90
- SSY $0.74
- Resistance Level
- ALLR $1.14
- SSY $0.88
- Average True Range (ATR)
- ALLR 0.08
- SSY 0.04
- MACD
- ALLR 0.02
- SSY -0.00
- Stochastic Oscillator
- ALLR 66.67
- SSY 21.36
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.
About SSY SunLink Health Systems Inc.
SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operate licensed-bed, acute care hospitals, which includes bed geriatric psychology unit, and nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.